rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-12-19
|
pubmed:abstractText |
Children with acute lymphoblastic leukemia are treated with intensive chemotherapy resulting in profound immuno suppression. Therefore treatment with trimethoprim-sulfamethoxazole (TMP-SMX) may be used for prophylaxis against infections both with bacteria and Pneumocystis carinii in some departments. The use of TMP-SMX for prophylaxis during the induction therapy is not uniform in the four departments of pediatric oncology in Denmark. This gave us the opportunity to describe the effect of TMP/SMX on bacterial infections in children with ALL during the induction therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0907-8916
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-7
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:11767129-Anti-Bacterial Agents,
pubmed-meshheading:11767129-Antibiotic Prophylaxis,
pubmed-meshheading:11767129-Bacteremia,
pubmed-meshheading:11767129-Child, Preschool,
pubmed-meshheading:11767129-Female,
pubmed-meshheading:11767129-Humans,
pubmed-meshheading:11767129-Immunocompromised Host,
pubmed-meshheading:11767129-Male,
pubmed-meshheading:11767129-Opportunistic Infections,
pubmed-meshheading:11767129-Pneumocystis Infections,
pubmed-meshheading:11767129-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11767129-Retrospective Studies,
pubmed-meshheading:11767129-Treatment Outcome,
pubmed-meshheading:11767129-Trimethoprim-Sulfamethoxazole Combination
|
pubmed:year |
2001
|
pubmed:articleTitle |
Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
|
pubmed:affiliation |
Department of Pediatrics, University Hospital of Aarhus.
|
pubmed:publicationType |
Journal Article
|